Abstract | OBJECTIVE: METHODS: RESULTS: Among 264 PTC patients, 104 (39.4%) patients received TT and 160 (60.6%) patients received LT. With a median follow-up of 50 months (interquartile range, 34 to 74 months), 7 patients (2.65%) experienced recurrence. The 5-year RFS in the TT and LT groups was 96.1% and 97.7%, respectively, and was not significantly different (P = .765). Similar results were found when excluding patients who received radioiodine ablation, which were 97.7% and 97.4%, respectively (P = .752). Age ≥55 years (hazard ratio, 7.368; P = .018) and multifocality in the ispi-lateral lobe (hazard ratio, 10.059; P =.006) were identified as independent risk factors of recurrence. CONCLUSION: For unilateral TNM T1 and T2 PTC patients with lateral lymph node metastasis, there was no significant difference in the effect of TT and LT for RFS in the absence of other risk factors during the follow-up period. Patient age ≥55 years with multifocality in the unilateral lobe might be independent risk factors for prognosis.
|
Authors | Zhihong Wang, Jingzhe Xiang, Zhiqiang Gui, Yuan Qin, Wei Sun, Jiapeng Huang, Liang He, Wenwu Dong, Dalin Zhang, Ting Zhang, Liang Shao, Chengzhou Lv, Ping Zhang, Hao Zhang |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
Vol. 26
Issue 10
Pg. 1085-1092
(Oct 2020)
ISSN: 1530-891X [Print] United States |
PMID | 33471710
(Publication Type: Journal Article)
|
Copyright | © 2020 American Association of Clinical Endocrinologists. Published by Elsevier, Inc. All rights reserved. |
Chemical References |
|
Topics |
- Carcinoma, Papillary
(surgery)
- Follow-Up Studies
- Humans
- Iodine Radioisotopes
- Lymph Nodes
- Lymphatic Metastasis
- Neoplasm Recurrence, Local
- Retrospective Studies
- Thyroid Cancer, Papillary
(surgery)
- Thyroid Neoplasms
(surgery)
- Thyroidectomy
|